Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Textual 1)

v3.5.0.2
Stockholders' Equity (Details Textual 1)
3 Months Ended 12 Months Ended
Sep. 30, 2014
$ / shares
shares
Sep. 30, 2016
USD ($)
$ / shares
shares
Sep. 30, 2015
USD ($)
$ / shares
shares
Jun. 30, 2016
$ / shares
shares
Sep. 30, 2016
CAD / shares
Stockholders Equity Note [Line Items]          
Exercise price | $ / shares   $ 3.00 $ 0.004    
Issuance of cash   $ 582,511      
Gross proceeds of cash   1,903,514      
Increase value in additional paid in capital and accumulated deficit   $ 29,594      
Preferred stock, par value | $ / shares   $ 0.001   $ 0.001  
Common stock, par value | $ / shares   $ 0.001   $ 0.001  
Common stock issued and outstanding exchanged basis | shares   1,014,011      
Stock-based compensation expense   $ 31,818 $ 39,906    
Weighted average contractual term   2 years 6 months      
Proceeds from the exercise of warrants   $ 256,940      
Stock options [Member]          
Stockholders Equity Note [Line Items]          
Number of stock options outstanding | shares   856,250   856,250  
Recognized as stock option liability   $ 260,969      
Aggregate intrinsic value of stock options outstanding   1,982,263 329,051    
Aggregate intrinsic value of stock options exercisable   1,728,712 $ 326,614    
Unrecognized compensation expense   263,437      
Aggregate intrinsic value of unvested stock options   $ 85,094      
Amendment shares of stock option exercise price | shares   43,750      
Stock options [Member] | 1.52 [Member]          
Stockholders Equity Note [Line Items]          
Exercise price | (per share)   $ 1.52     CAD 2.00
Number of stock options outstanding | shares   25,000      
Series A Preferred Stock [Member]          
Stockholders Equity Note [Line Items]          
Preferred stock, shares issued | shares   278,530   278,530  
Series A Preferred Stock [Member] | Exchange Agreement          
Stockholders Equity Note [Line Items]          
Preferred stock, shares issued | shares 278,530        
Preferred stock, par value | $ / shares $ 1.00        
Preferred Stock, rate of dividend 3.00%        
Series B Preferred Stock [Member]          
Stockholders Equity Note [Line Items]          
Series B Preferred stock dividend, shares | shares   50,793      
Preferred stock, shares issued | shares   902,238   902,238  
Preferred Stock, rate of dividend       9.00%  
Description of dividend payment       Each share of Series B Preferred Stock is convertible into 2.5 shares of common stock equating to a conversion price of $3.20 (the "Conversion Price") and will automatically convert to common stock at the earlier of 24 hours following regulatory approval of VAL-083 with a minimum closing bid price of $8.00 or five years from the final closing dates. The holders of the Series B Preferred Stocks are entitled to an annual cumulative, in arrears dividend at the rate of 9% payable quarterly. The 9% dividend shall accrue quarterly commencing on the date of issue and be payable quarterly on June 30, September 30, December 31, and March 31 of each year commencing on June 30, 2016.  
Accumulated deficit [Member]          
Stockholders Equity Note [Line Items]          
Series B Preferred stock dividend   $ 307,298      
Investor Warrant Amendments [Member]          
Stockholders Equity Note [Line Items]          
Number of stock options outstanding | shares       181,156  
Investor Warrant Exercises [Member]          
Stockholders Equity Note [Line Items]          
Exercise price | $ / shares   $ 3.144      
Proceeds from the exercise of warrants   $ 134,900      
2015 Investor Warrants [Member]          
Stockholders Equity Note [Line Items]          
Exercise price | $ / shares     $ 3.00    
Warrants expiration date     Jul. 31, 2020    
Common stock, par value | $ / shares     $ 2.40    
Common stock shares issued on exercise of warrants | shares     1,069,417    
Issuance of shares and warrants - net of issue costs, shares | shares     1,069,417    
Proceeds from the exercise of warrants   $ 120,000 $ 2,566,660    
Term of warrants     5 years    
2015 Agent Warrants [Member]          
Stockholders Equity Note [Line Items]          
Sale of stock description     Under the Company's engagement agreements with these placement agents, the Company agreed to pay up to a 7% cash commission and issue warrants to purchase shares of common stock (the "2015 Agent Warrants") up to the number of shares of our common stock equal to 5% of the aggregate number of shares sold in the Offering by such placement agent.    
Total cash commission     $ 80,575    
Exercise price | $ / shares     $ 3.00    
Warrants expiration date     Jul. 15, 2020    
Investor warrants, description   680 of the 2015 Agent Warrants were exercised for cash proceeds of $2,040 and 1,000 of the 2015 Agent Warrants were exercised on a cashless basis for 594 shares of common stock.      
Number of warrants issued | shares   1,000 23,477    
Proceeds from the exercise of warrants   $ 2,040